Amylyx Pharmaceuticals's chart data is dated 2026-10-09. There is no active technical signal. There are 16 published signal records.
Amylyx Pharmaceuticals last closed at $28.14 (+3.46%) on 2026-10-09. Listed on Nasdaq. Trailing 12 months PER is -19.9×. Its overall grade ranks 104 of 738 stocks in Healthcare.
About this company
Amylyx Pharmaceuticals last closed at $28.14 (+3.46%) on 2026-10-09. Listed on Nasdaq.
Details →Reported results
Position in sector
Healthcare · Overall A · 104/738
Valuation grade A
Related stocks
- BiogenCompetitor
희귀·신경퇴행성 질환 치료제 영역에서 경쟁
- EisaiCompetitor
알츠하이머 치료제 시장에서 경쟁
- Eli Lilly and CompanyCompetitor
알츠하이머 등 CNS 신약 개발 경쟁
ETFs holding this stock
SPDR S&P Pharmaceuticals ETF · Virtus LifeSci Biotech Clinical Trials ETF · Direxion Daily Pharmaceutical & Medical Bl 3X Shs
Details →About Amylyx Pharmaceuticals
- What technical signals does Amylyx Pharmaceuticals (AMLX) have?
- Amylyx Pharmaceuticals current technical signals: no active technical signal.
- Is Amylyx Pharmaceuticals a cup-and-handle pattern?
- No. Amylyx Pharmaceuticals has no valid Cup signal right now.
- What published figures are available for Amylyx Pharmaceuticals?
- Market cap: $3.09B. Trailing 12 months PER: -19.9×. Latest quarter PBR: 12.65×. Dividend yield: 0.00%.
Like these rules? Backtest them.
Run this signal on this ticker in the free backtest builder — same window, no install.
Backtest this rule ↗Major stocks in the same sector
2026-10-09 dataset
Turn what you saw on this name into a strategy
Ask Q about Amylyx Pharmaceuticals, or open the plan table on the main site.
From the names you found to a trading rule
Tell Q about the stocks you found to place orders with your conditions.